These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 29668523)
1. Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh-Dole Act. Silva PJ; Ramos KS Acad Med; 2018 Aug; 93(8):1135-1141. PubMed ID: 29668523 [TBL] [Abstract][Full Text] [Related]
2. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act. Colaianni A; Cook-Deegan R Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286 [TBL] [Abstract][Full Text] [Related]
3. University-based science and biotechnology products: defining the boundaries of intellectual property. Kesselheim AS; Avorn J JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775 [TBL] [Abstract][Full Text] [Related]
4. Bayh-Dole: if we knew then what we know now. Boettiger S; Bennett AB Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405 [No Abstract] [Full Text] [Related]
5. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms. Sarpatwari A; Kesselheim AS; Cook-Deegan R J Health Polit Policy Law; 2022 Dec; 47(6):879-895. PubMed ID: 35877952 [TBL] [Abstract][Full Text] [Related]
6. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business. Fernandes M; Miska D Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036 [No Abstract] [Full Text] [Related]
7. Intellectual property. University licensing and the Bayh-Dole Act. Thursby JG; Thursby MC Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996 [No Abstract] [Full Text] [Related]
8. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act. Berman EP Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798 [TBL] [Abstract][Full Text] [Related]
9. The Bayh-Dole Act: a model for promoting research translation? Loewenberg S Mol Oncol; 2009 Apr; 3(2):91-3. PubMed ID: 19383372 [TBL] [Abstract][Full Text] [Related]
11. Academic medical centers as innovation ecosystems to address population -omics challenges in precision medicine. Silva PJ; Schaibley VM; Ramos KS J Transl Med; 2018 Feb; 16(1):28. PubMed ID: 29448963 [TBL] [Abstract][Full Text] [Related]
12. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study. Treasure CL; Avorn J; Kesselheim AS Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985 [TBL] [Abstract][Full Text] [Related]
13. Research and the Bayh-Dole Act. Reczek PR Science; 2004 Jan; 303(5654):40. PubMed ID: 14704412 [No Abstract] [Full Text] [Related]
14. COVID-IP: staring down the Bayh-Dole Act with 2020 vision. Paradise J J Law Biosci; 2020; 7(1):lsaa073. PubMed ID: 33033619 [TBL] [Abstract][Full Text] [Related]
15. Patent and license pearls and pitfalls for taking an idea to the marketplace. Mukharji I J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827 [TBL] [Abstract][Full Text] [Related]
16. MORE THAN MONEY: THE EXPONENTIAL IMPACT OF ACADEMIC TECHNOLOGY TRANSFER. McDevitt VL; Mendez-Hinds J; Winwood D; Nijhawan V; Sherer T; Ritter JF; Sanberg PR Technol Innov; 2014 Nov; 16(1):75-84. PubMed ID: 25061505 [TBL] [Abstract][Full Text] [Related]
18. Bayh-Dole: almost 25. Kennedy D Science; 2005 Mar; 307(5714):1375. PubMed ID: 15746390 [No Abstract] [Full Text] [Related]
19. The Bayh-Dole Act, a lion without claws. Feldman AM Clin Transl Sci; 2015 Feb; 8(1):3-4. PubMed ID: 25675969 [No Abstract] [Full Text] [Related]
20. March-in rights under the Bayh-Dole Act: the NIH's paper tiger? O'Brien W Seton Hall Law Rev; 2013 Nov; 43(4):1403-32. PubMed ID: 24308083 [No Abstract] [Full Text] [Related] [Next] [New Search]